Relationship between blood-aqueous barrier disruption and ischemic macular edema in patients with branch or central retinal vein occlusion: Effects of sub-tenon triamcinolone acetonide injection

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 6, 2007, Pages 577-584

  Asano, Sayaka ^a   Miyake, Kensaku ^a   Miyake, Sampei ^a   Ota, Ichiro ^a  

^a Miyake Eye Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LASER FLARE CELL METER; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA ISCHEMIA; RETINA MACULA EDEMA; STATISTICAL ANALYSIS; THICKNESS; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BLOOD-AQUEOUS BARRIER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; ISCHEMIA; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 36749051294     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0057     Document Type: Article

References (32)

1. Miyake, K., and Ibaraki, N. Prostaglandins and cystoid macular edema. Surv. Ophthalmol. 47(Suppl. 1):S203-S218, 2002.
2. Kent, D., Vinores, S.A., and Campochiaro, P.A. Macular oedema: The role of soluble mediators. Br. J. Ophthalmol. 84:542-545, 2000.
3. Miyake, K. Prevention of cystoid macular edema after lens extraction by topical indomethacin (I). A preliminary report. Albrecht Von Graefe's Arch. Klin. Exp. Ophthalmol. 203:81-88, 1977.
4. Flach, AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv. Ophthalmol. 36:259-284, 1992.
5. Rossetti, L., Chaudhuri, J., and Dickersin, K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery: The results of a meta-analysis. Ophthalmology 105:397-405, 1998.
6. Miyake, K. Prevention of cystoid macular edema after lens extraction by topical indomethacin (II). A control study in bilateral extraction. Jpn. J. Ophthalmol. 22:80-94, 1978.
7. Miyake, K. Cystoid macular edema as part of diffuse intraocular symptoms. Folia Ophthalmol. Jpn. 46:219-231, 1995.
8. Miyake, K., Masuda, K., Shirato, S., et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: A multicentered, prospective trial. Jpn. J. Ophthalmol. 44:58-67, 2000.
9. Patz, A., Schatz, H., Berkow, J.W., et al. Macular edema: An overlooked complication of diabetic retinopathy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 77:34-42, 1973.
10. Clarkson, J.G., Gass, J.D.M., Curtin V.T., et al. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am. J. Ophthalmol. 98:271-282, 1984.
11. Clarkson, J.G., Chuang, E., Goss, D., et al. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 102:1425-1433, 1995.
12. Aiello, J.P., Avery, R.L., Arrigg, P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabtic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487, 1994.
13. Vinores, S.A., Sen, H., and Campochiaro, P.A. An adenosine agonist and prostaglandin E1 cause breakdown of blood-retinal barrier by opening tight junctions between vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 33:1870-1878, 1992.
14. Ozaki, H., Hayashi, H., Vinores, S.A., et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp. Eye Res. 64:505-517, 1997.
15. Murata, T., Nakagawa, K., Khalil, A., et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab. Invest. 74:819-825, 1996.
16. Jonas, J.B., and Sofker, A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am. J. Ophthalmol. 132:425-427, 2001.
17. Martidis, A., Duker, J.S., Greenberg, P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-927, 2002.
18. Greenberg, P.B., Martidis, A., Rogers, A.H., et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. [letter] Br. J. Ophthalmol. 86:247-248, 2002.
19. Ip, M.S., and Kumar, K.S. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch. Ophthalmol. 120:1217-1219, 2002.
20. Levin, D.S., Han, D.P., Dev, S., et al. Sub-tenon's depot corticosteroid injections in patients with a history of corticosteroid induced intraocular pressure elevation. Am. J. Ophthalmol. 133:196-202, 2002.
21. Wakabayashi, T., Okada, A.A., Morimura, Y., et al. Trans-Tenon retrobulbar triamcinolone infusion for macular edema in central and branch retinal vein occlusions. Retina 24:964-967, 2004.
22. Vinten, M., Larsen, M., Lund-Andersen, H., et al. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema. Acta. Ophthalmol. Scand. 85:21-26, 2007.
23. Nozik, R.A. Periocular injection of steroids. Trans. Am. Acad. Ophthalmol. Otolaryngol. 76:695-705, 1972.
24. Schlaegel, T.F., Jr. and Weber, J.C. Treatment of pars planitis: Part II. Corticosteroids. Surv. Ophthalmol. 22:120,125-130, 1977.
25. Peyman, G.A., and Moshfeghi, D.M. Intravitreal triamcinolone acetonide. Retina 24:488-490, 2004.
26. Floman, N., and Zor, U. Mechanism of steroid action in ocular inflammation: Inhibition of prostaglandin production. Invest. Ophthalmol. 16:69-73, 1977.
27. Ishibashi, T., Miki, K., Sorgente, N., et al. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch. Ophthalmol. 103:708-711, 1985.
28. Bandi, N., and Kompella, U.B. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur. J. Pharmacol. 425:109-116, 2001.
29. Miyake, K., Miyake, T., and Kayazawa, F. Blood-aqueous barrier in eyes with retinal vein occlusion. Ophthalmology 99:906-910, 1992.
30. Miyake, K., Asakura, M., Miyake, T., et al. The blood ocular barrier in the branch retinal vein occlusion. Part I. Nippon Ganka Gakkai Zasshi 88:746-750, 1984.
31. Oshika, T. Blood-aqueous barrier function in branch retinal vein occlusion. Folia Ophthalmol. Jpn. 41:554-559, 1990.
32. Sawa, M., Tsurimaki, Y., Tsuru, T., et al. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn. J. Ophthalmol. 32:132-142, 1988.